Zenabis Global (OTCMKTS:ZBISF) has announced the assigning of its term sheet with Farmako GmBH for the supply of medical cannabis to German to its subsidiary ZenPharm’s.
The term sheet is for supplying EU Good Manufacturing Practices certified medical marijuana, and it has also amended the terms for the provision of a minimum volume guarantee. The company has also announced that it has received a sales license amendment from Health Canada for Zenabis Sterllaton.
Zenabis announced term sheet with Farmako in April last year
The company announced a term sheet with Farmako on April 29 last year for medicinal marijuana supply to Germany. It has assigned the term sheet to ZenPharm, its Malta-based subsidiary, to process EU GMP compliant cannabis from Zenabis and supply it to Farmako. The subsidiary is expected to supply at least 500 kg/year for three years.
However, this will be subject to ZenPharm obtaining EU GMP certification that it expects in the third quarter of this year. The company expects to commence shipment to Farmako in the fourth quarter with the supply of cannabis oils expected to begin in 2020.
Zenabis to increase supply in Europe as from Q4 2020
Zenabis CEO, Kevin Coft indicated that the company’s assignment of the term sheet and the provision of additional minimum volume reinforce the company’s impetus internationally. The CEO added that partnerships with main distributors such as Farmako are important as to will enhance accessibility go medicinal marijuana products to patients. Zenabis is anticipating to increase supply across Europe in Q4 2020.
Katrin Eckmans, the CEO of Farmako, stated that after visiting the Zenabis facility in Canada at the end of last year, he was impressed. Eckmans said that they had visited several facilities, and the Zenabis facility stood out with high professional standards and quality throughout the company even when it was operating on a large scale. The CEO added that the cannabis growing approach of Zenabis plus the Natrix Science’s innovative experience with pharmaceutical products was a perfect interplay to offer a wide range of high premium medicinal cannabis products.
Business intelligence from Akerna Corp (NASDAQ:KERN) Says Liquor Sales are Up 10% Year-over-Year
Post Views: 334 Liquor sales are up 10% year-over-year according to business intelligence from Akerna Corp (NASDAQ:KERN). Red wine took...
Pyxis Tankers Inc. (NASDAQ:PXS) Announce Q1 2020 Financial Results Amid COVID-19 Uncertainties
Post Views: 179 Pyxis tankers Inc. (NASDAQ:PXS) has announced its unaudited financial results for the quarter that ended March 31,...
Innovative Industrial Properties Inc (NYSE:IIPR) Enters Into a Lease Amendment Agreement with Green Leaf
Post Views: 197 With pot being legalized in many countries, the market is likely to get even bigger. As a...
Liberty Leaf Holdings Ltd (OTCMKTS:LIBFD) Takes Over Nova Mentis Biotech Corp And Add Synergies To Its Cannabis Assets In The Wellness And Health Sector
Post Views: 200 Liberty Leaf Holdings Ltd (OTCMKTS:LIBFD) gained access to the psilocybin by acquiring Nova Mentis Biotech Corp. The...
Aleafia Health Inc (OTCMKTS:ALEAF) Begins Cultivation At Its Entire Niagara Facility And Provides Consistent Supplies for Health: Settles Disputes With Aphria
Post Views: 321 Aleafia Health Inc (OTCMKTS:ALEAF) will commence cultivation operations at its whole Niagara facility. It obtained a license...
Pure Capital Calls For Shareholders Meeting of Therapix Biosciences Ltd (NASDAQ:TRPX): Demands For Dismissal Of Board Members
Post Views: 253 Pure Capital called for an emergency meeting of investors of Therapix Biosciences Ltd (NASDAQ:TRPX) to discuss actions...